This is a preserved record of the BIOSPAIN 2021 event website, kept online so old links keep working. The event took place on 27 September – 1 October 2021 and this site is not affiliated with AseBio, Kenes Group or the Government of Navarra. For current BIOSPAIN editions, see asebio.com. The original page is also stored at the Internet Archive.
BIOSPAIN 2021 / Program
The BIOSPAIN 2021 program
Sessions ran Monday 27 September through Friday 1 October 2021 — on demand from day one, and in hybrid format from Baluarte in Pamplona-Iruña from Wednesday 29 September.
How the program was structured
The agenda was organized into daily tracks — Monday 27 September to Friday 1 October — plus a block of on-demand sessions available throughout the event. In-person attendance at Baluarte was limited by the Government's COVID-19 restrictions in force at the end of September 2021, so every session was also streamed on the event's virtual platform.
On-demand sessions (as published)
The role of associations as industry growth drivers: achievements & future strategies
- Moderator: Ion Arocena — Managing Director, AseBio (Spain)
- Joseph Damond — Deputy Chief of Policy & Executive VP, International Affairs, BIO (USA)
- Claire Skentelbery — Director General, EuropaBio (Belgium)
- Vicki L. Loise — CEO, SLAS (USA)
Hospitals dynamizing the biotech industry
- Moderator: Diego Velasco — Head of Innovation, Ramón y Cajal Research Institute (Spain)
The full day-by-day agenda, with every speaker and session, is preserved in the archived program page at the Internet Archive.
Investment Forum
Alongside the panel sessions, BIOSPAIN's Investment Forum gave selected companies slots to present to investors; on-site registrants had access to the presentations, the trade exhibition hall and the program sessions (see registration).